Rapid Micro Biosystems, Inc. (RPID)

Market Cap	190.22M
Revenue (ttm)	29.65M
Net Income (ttm)	-44.83M
Shares Out	43.83M
EPS (ttm)	-1.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	269,776
Open	4.050
Previous Close	4.030
Day's Range	4.050 - 4.500
52-Week Range	0.650 - 4.500
Beta	1.34
Analysts	Buy
Price Target	8.00 (+84.33%)
Earnings Date	Aug 1, 2025

About RPID

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial qu...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 15, 2021
• Employees: 163
• Stock Exchange: NASDAQ
• Ticker Symbol: RPID
• Website: https://www.rapidmicrobio.com

Financial Performance

In 2024, Rapid Micro Biosystems's revenue was $28.05 million, an increase of 24.57% compared to the previous year's $22.52 million. Losses were -$46.89 million, -10.63% less than in 2023.

Analyst Summary

According to one analyst, the rating for RPID stock is "Buy" and the 12-month stock price target is $8.0.

Price Target

$8.0

(84.33% upside)

Analyst Consensus: Buy